Abstract
Bleeding after cardiac surgery is a common and severe complication leading to transfusion of multiple blood products and increased morbidity and mortality. Young age, low weight, polycythemia, profound hypothermia, and complex cardiac surgery are risk factors for severe bleeding. In addition, we need to account for the growing use of drugs that affect platelet aggregation and coagulation, which could increase the bleeding risk if not managed correctly.
Point-of-Care (POC) testing allows monitoring of one of the most problematic aspects that concern the health care providers when faced with surgical procedures, the hemostasis. POC bedside tests allow operating room or the intensive care diagnoses of coagulopathy of diverse etiology. Evidence-based algorithms integrate POC testing as one of the essential mechanisms to limit blood product transfusion, adverse events and allow goal-directed therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal HS, Barrett SS, Barry K, et al. Association of blood products administration during cardiopulmonary bypass and excessive postoperative bleeding in pediatric cardiac surgery. Pediatr Cardiol. 2015a;36:459–67.
Agarwal S, Johnson RI, Shaw M. Preoperative point-of-care platelet function testing in cardiac surgery. J Cardiothorac Vasc Anesth. 2015b;29:333–41.
American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on perioperative blood management*. Anesthesiology. 2015;122:241–75.
Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80(8):1998–2005.
Cammerer U, Dietrich W, Rampf T, et al. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg. 2003;96(1):51–7.
Cappabianca G, Rotunno C, de Luca Tupputi Schinosa L, et al. Protective effects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth. 2011;25(1):156–65.
Chee YL, Crawford JC, Watson HG, Greaves M. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol. 2008;140(5):496–504.
Chowdhury M, Shore-Lesserson L, Mais AM, et al. Thromboelastograph with platelet mapping (TM) predicts postoperative chest tube drainage in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2014;28(2):217–23.
Craft RM, Chavez JJ, Bresee SJ, et al. A novel modification of the Thromboelastograph assay, isolating platelet function, correlatos with optical platelet aggregation. J Lab Clin Med. 2004;143:3001–9.
Craig J, Aguiar-Ibanez R, Bhattacharya S, et al. HTA programme: health technology assessment report 11—the clinical and cost-effectiveness of thromboelastography/thromboelastometry. NHS Quality Improvement Scotland. 2008. www.nhshealthquality.org. Accessed Aug 2015.
Despotis G, Avidan M, Eby C. Prediction and management of bleeding in cardiac surgery. J Thromb Haemost. 2009;7(Suppl 1):111–7.
Dirkmann D, Gorlinger K, Dusse F, et al. Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: a step towards earlier decision making. Acta Anaesthesiol Scand. 2013;57:594–603.
Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep. 2004;3(5):324–30.
Eaton MP, Iannoli EM. Coagulation considerations for infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth. 2011;21(1):31–42.
Erdoes G, Koster A, Meesters MI, et al. The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the haemostasis and transfusion scientific Subcommittee of the European Association of Cardiothoracic Anaesthesiology. Anaesthesia. 2019;74(12):1589–600.
Erdoes G, Koster A, Ortmann E, et al. A European consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients. Anaesthesia. 2021;76(3):381–92.
Gertler R, Hapfelmeier A, Tassani-Prell P, et al. The effect of cyanosis on perioperative platelet function as measured by multiple electrode aggregometry and postoperative blood loss in neonates and infants undergoing cardiac surgery. Eur J Cardiothorac Surg. 2014;28:ezu412.
Görlinger K, Dirkmann D, Solomon C, et al. Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability. Br J Anaesth. 2013a;110:222–30.
Görlinger K, Shore-Lesserson L, Dirkmann D, et al. Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth. 2013b;27(4 Suppl):S20–34.
Görlinger K, Pérez-Ferrer A, Dirkmann D, et al. The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management. Korean J Anesthesiol. 2019;72(4):297–322.
Haas T, Spielmann N, Mauch J, et al. Comparison of thromboelastometry (ROTEM®) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth. 2012;108(1):36–41.
Haas T, Görlinger K, Grassetto A, et al. Thromboelastometry for guiding bleeding management of the critically ill patient: a systematic review of the literature. Minerva Anestesiol. 2014;80(12):1320–35.
Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81(2):360–5.
Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958–65.
Ichikawa J, Kodaka M, Nishiyama K, et al. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28(4):1003–7.
Karam O, Demaret P, Shefler A, et al. Indications and effects of plasma transfusions in critically ill children. Am J Respir Crit Care Med. 2015;191(12):1395–402.
Karanjkar A, Kapoor PM, Sharan S, et al. A prospective randomized clinical trial of efficacy of algorithm-based point of care guided hemostatic therapy in cyanotic congenital heart disease surgical patients. J Card Crit Care TTS. 2020;3:8–16.
Karkouti K, Callum J, Crowther MA, et al. The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study. Anesth Analg. 2013;117(1):14–22.
Kozek-Langenecker SA, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30(6):270–382.
Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34(6):332–95.
Levy JH, Tanaka KA. Anticoagulation and reversal paradigms: is too much of a good thing bad? Anesth Analg. 2009;108(3):692–4.
Mace H, Lightfoot N, McCluskey S, et al. Validity of Thromboelastometry for rapid assessment of fibrinogen levels in heparinized samples during cardiac surgery: a retrospective, single-center, observational study. J Cardiothorac Vasc Anesth. 2016;30(1):90–5.
Miller BE, Mochizuki T, Levy JH, et al. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg. 1997a;85:1196–202.
Miller BE, Bailey JM, Mancuso TJ, Weinstein MS, Holbrook GW, Silvey EM, Tosone SR, Levy JH. Functional maturity of the coagulation system in children: an evaluation using thrombelastography. Anesth Analg. 1997b;84(4):745–8.
Mittermayr M, Velik-Salchner C, Stalzer B, et al. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Anesth Analg. 2009;108(3):743–50.
Nakayama Y, Nakajima Y, Tanaka KA, et al. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anesth. 2015;114:91–102.
National Institute for Health and Care Excellence. Detecting, managing, and monitoring hemostasis: viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems). 2014. https://www.nice.org.uk/guidance/dg13. Accessed Aug 2015.
Nuttall GA, Oliver WC, Santrach PJ, et al. Efficacy of a simple intraoperative transfusion algorithm for non-erythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 2001;94:773–81.
Perez-Ferrer A, Vicente-Sanchez J, Carceles-Baron MD, et al. Early thromboelastometry variables predict maximum clot firmness in children undergoing cardiac and non-cardiac surgery. Br J Anaesth. 2015;115(6):896–902.
Ranucci M, Bianchi P, Cotza M, et al. Fibrinogen levels and postoperative chest drain blood loss in low-weight (<10 kg) children undergoing cardiac surgery. Perfusion. 2019;34(8):629–36.
Raphael J, Mazer CD, Subramani S, et al. Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in cardiac surgery patients. Anesth Analg. 2019;129(5):1209–21.
Samkova A, Blatny J, Fiamoli V, Dulicek P, Parizkova E. Significance and causes of abnormal preoperative coagulation test results in children. Haemophilia. 2012;18(3):e297–301.
Slaughter TF, Sreeram G, Sharma AD, et al. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis. 2001;12(2):85–93.
Solomon C, Sørensen B, Hochleitner G, et al. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg. 2012;114(4):721–30.
Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013;19(2):R76.
Spiess BD, Gillies BS, Chandler W, et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 1995;9(2):168–73.
Spiezia L, Campello E, Simioni P. “Hypocoagulable” thromboelastography profiles in patients with cyanotic congenital heart disease: facts or technical artifacts? Int J Cardiol. 2013;168(3):2914.
Szekely A, Cserep Z, Sapi E, et al. Risks and predictors of blood transfusion in pediatric patients undergoing open-heart operations. Ann Thorac Surg. 2009;87:187–97.
Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009;108(5):1433–46.
Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastography platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol. 2005;46:1705–9.
Theusinger OM, Stein P, Levy JH. Point of care and factor concentrate-based coagulation algorithms. Transfus Med Hemother. 2015;42(2):115–21.
Venema LF, Post WJ, Hendriks HG, et al. An assessment of clinical interchangeability of TEG and RoTEM thromboelastographic variables in cardiac surgical patients. Anesth Analg. 2010;111(2):339–44.
Weber CF, Klages M, Zacharowski K. Perioperative coagulation management during cardiac surgery. Curr Opin Anaesthesiol. 2013;26(1):60–4.
Willems A, Harrington K, Lacroix J, et al. Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis. Crit Care Med. 2010;38:649–56.
Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg. 1999;89:57–64.
Wolf MJ, Maher KO, Kanter KR, et al. Early postoperative bleeding is independently associated with increased surgical mortality in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2014;148:631–6.
Yamamoto T, Wolf HG, Sinzobahamvya N, et al. Prolonged activated clotting time after protamine administration does not indicate residual heparinization after cardiopulmonary bypass in Pediatric Open-Heart Surgery. Thorac Cardiovasc Surg. 2015;63(5):397–403.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pérez Ferrer, A., Motta, P. (2023). Perioperative Coagulation Monitoring in Congenital Heart Disease Patients. In: Dabbagh, A., Hernandez Conte, A., Lubin, L.N. (eds) Congenital Heart Disease in Pediatric and Adult Patients. Springer, Cham. https://doi.org/10.1007/978-3-031-10442-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-031-10442-8_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-10441-1
Online ISBN: 978-3-031-10442-8
eBook Packages: MedicineMedicine (R0)